KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Bausch Health Companies (BHC) over the last 16 years, with Sep 2025 value amounting to $5.0 million.

  • Bausch Health Companies' Gains from Investment Securities changed negligibly% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.0 million, marking a year-over-year increase of 12.50%. This contributed to the annual value of $26.0 million for FY2024, which is 8.33% up from last year.
  • As of Q3 2025, Bausch Health Companies' Gains from Investment Securities stood at $5.0 million, which was up 66.67% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Gains from Investment Securities ranged from a high of $41.0 million in Q1 2021 and a low of $1.0 million during Q3 2022.
  • Moreover, its 3-year median value for Gains from Investment Securities was $5.0 million (2025), whereas its average is $6.7 million.
  • As far as peak fluctuations go, Bausch Health Companies' Gains from Investment Securities slumped by 75.00% in 2022, and later soared by 700.00% in 2023.
  • Bausch Health Companies' Gains from Investment Securities (Quarterly) stood at $4.0 million in 2021, then crashed by 75.00% to $1.0 million in 2022, then remained steady at $1.0 million in 2023, then surged by 200.00% to $3.0 million in 2024, then remained steady at $5.0 million in 2025.
  • Its Gains from Investment Securities stands at $5.0 million for Q3 2025, versus $3.0 million for Q2 2025 and $16.0 million for Q1 2025.